2012
DOI: 10.1002/ajmg.a.35564
|View full text |Cite
|
Sign up to set email alerts
|

New proposed clinico‐radiologic and molecular criteria in hypochondroplasia: FGFR 3 gene mutations are not the only cause of hypochondroplasia

Abstract: We applied a comprehensive set of clinical and radiological criteria for the diagnosis of hypochondroplasia (HCH) in 160 patients with short stature 58 of whom were diagnosed to have HCH. Taking into account the genotypic and phenotypic variations in HCH, we conducted a study with these 58 patients and tested them for mutations in the fibroblast growth factor receptor 3 (FGFR3) and the short stature homeobox (SHOX) gene. We characterized the phenotypes by clinical and radiologic findings. In the patients with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
19
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(22 citation statements)
references
References 24 publications
(41 reference statements)
2
19
0
1
Order By: Relevance
“…The best known examples are thanatophoric dysplasia, achondroplasia, and hypochondroplasia, each associated with different locations of the mutation. The clinical presentation of hypochondroplasia is milder and more variable than achondroplasia and includes rhizomelic limb shortening, limitation of elbow extension, brachydactyly, relative macrocephaly, generalized laxity, and specific radiologic features (5,108). We recently reported a novel activating FGFR3 mutation in a family with proportionate short stature (109).…”
Section: Fibroblast Growth Factor Signallingmentioning
confidence: 99%
“…The best known examples are thanatophoric dysplasia, achondroplasia, and hypochondroplasia, each associated with different locations of the mutation. The clinical presentation of hypochondroplasia is milder and more variable than achondroplasia and includes rhizomelic limb shortening, limitation of elbow extension, brachydactyly, relative macrocephaly, generalized laxity, and specific radiologic features (5,108). We recently reported a novel activating FGFR3 mutation in a family with proportionate short stature (109).…”
Section: Fibroblast Growth Factor Signallingmentioning
confidence: 99%
“…As noted earlier, some patients with SHOX gene mutation were reported to have an overlapping phenotype with hypochondroplasia patients with FGFR3 gene mutation, although some patients did not have either SHOX or FGFR3 gene mutation among those in whom hypochondroplasia was clinically suspected.…”
Section: Achondroplasia and Hypochondroplasiamentioning
confidence: 67%
“…This difference in accurate diagnosis is presumably due to the difference in clinical and radiological features between achondroplasia and hypochondroplasia, as described previously. As noted earlier, some patients with SHOX gene mutation were reported to have an overlapping phenotype with hypochondroplasia patients with FGFR3 gene mutation, 10 although some patients did not have either SHOX orFGFR3 gene mutation among those in whom hypochondroplasia was clinically suspected.…”
Section: Achondroplasia and Hypochondroplasiamentioning
confidence: 76%
See 1 more Smart Citation
“…Hypochondroplasia (HCH; MIM #146000) is a skeletal dysplasia characterized by macrocephaly, short stature, stocky build, disproportionately short arms and legs, broad and short hands and feet, and mild joint laxity (Bellus et al, ; Rousseau et al, ). Radiological features include shortening of long bones with mild metaphyseal flare; mild to moderate brachydactyly; narrowing of inferior lumbar interpedicular distance; short, broad femoral neck; and squared, shortened ilia (Heselson, Cremin, & Beighton, ; Song et al, ). Less common but significant clinical features include scoliosis, mild genu varum , lumbar lordosis with protruding abdomen, acanthosis nigricans (Castro‐Feijóo et al, ), mild to moderate intellectual disability (9–20%), and temporal lobe dysplasia/epilepsy (Linnankivi, Mäkitie, Valanne, & Toiviainen‐Salo, ).…”
Section: Introductionmentioning
confidence: 99%